Internal Medicine, Endocrinology, Diabetes, & Metabolism · Newburgh, NY
NPI
1326144650
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1200 Route 300
Newburgh, NY, 12550
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
7,971 services
Medicare patients, 2024
546
Average age 71
Drug cost, 2024
$3.3M
7,671 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew S Leone was code J0897 (injection, denosumab, 1 mg), 2,400 times for 28 patients. In total Matthew S Leone billed 7,971 services in 53 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,400 | 28 | $20.72 | $50K |
| 99214 Office E&M - Established | Office | 867 | 480 | $93.76 | $81K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 725 | 431 | $12.92 | $9,365 |
| 36415 Venipuncture Blood Collection | Office | 701 | 418 | $8.62 | $6,042 |
| 80053 Clinical Chemistry | Office | 524 | 368 | $10.32 | $5,409 |
| 80061 Clinical Chemistry | Office | 406 | 274 | $13.09 | $5,314 |
| 84443 Clinical Chemistry | Office | 396 | 311 | $16.40 | $6,496 |
| 83036 Blood Count | Office | 382 | 263 | $9.50 | $3,630 |
| 82607 Clinical Chemistry | Office | 275 | 201 | $14.72 | $4,048 |
| 82306 Clinical Chemistry | Office | 240 | 197 | $28.87 | $6,929 |
| 82043 Clinical Chemistry | Office | 190 | 159 | $5.64 | $1,072 |
| 82570 Clinical Chemistry | Office | 188 | 158 | $5.06 | $952 |
| 83970 Clinical Chemistry | Office | 147 | 126 | $40.26 | $5,919 |
| 96372 Injection Administration | Office | 97 | 37 | $11.41 | $1,107 |
| 84439 Clinical Chemistry | Office | 84 | 68 | $8.82 | $740 |
By year: 2022 $167K for 6,660 services; 2023 $192K for 7,686 services; 2024 $201K for 7,971 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 701 | 418 | $8.62 | $6,042 |
| 80053 Clinical Chemistry | 524 | 368 | $10.32 | $5,409 |
| 80061 Clinical Chemistry | 406 | 274 | $13.09 | $5,314 |
| 84443 Clinical Chemistry | 396 | 311 | $16.40 | $6,496 |
| 83036 Blood Count | 382 | 263 | $9.50 | $3,630 |
| 82607 Clinical Chemistry | 275 | 201 | $14.72 | $4,048 |
| 82306 Clinical Chemistry | 240 | 197 | $28.87 | $6,929 |
| 82043 Clinical Chemistry | 190 | 159 | $5.64 | $1,072 |
| 82570 Clinical Chemistry | 188 | 158 | $5.06 | $952 |
| 83970 Clinical Chemistry | 147 | 126 | $40.26 | $5,919 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S Leone prescribed most often to Medicare patients was Levothyroxine Sodium, with 823 prescriptions and refills. In total Matthew S Leone wrote 7,671 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 823 | 2,107 | 211 | $11K |
| Ozempic Semaglutide | 663 | 1,232 | 162 | $1.2M |
| Atorvastatin Calcium Generic | 631 | 1,771 | 219 | $5,277 |
| Metformin Hcl Er Metformin Hcl | 497 | 1,345 | 158 | $7,343 |
| Metformin Hcl Generic | 439 | 1,193 | 132 | $7,906 |
| Jardiance Empagliflozin | 347 | 818 | 92 | $470K |
| Alendronate Sodium Generic | 247 | 628 | 74 | $2,449 |
| Rosuvastatin Calcium Generic | 214 | 565 | 69 | $3,132 |
| Lisinopril Generic | 209 | 611 | 78 | $1,206 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 206 | 517 | 68 | $34K |
| Trulicity Dulaglutide | 202 | 366 | 48 | $360K |
| Glimepiride Generic | 182 | 482 | 57 | $1,245 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 162 | 458 | 70 | $15K |
| Januvia Sitagliptin Phosphate | 150 | 366 | 47 | $194K |
| Tresiba Flextouch U-100 Insulin Degludec | 139 | 339 | 46 | $100K |
Brand drugs: 2,914 claims; generic drugs: 4,081 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Matthew S Leone were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.